BNET Industries
Last Fiscal Year Sales:$137.8M
- Public
- US
Dow Jones Description
E-Z-EM, Inc. is a leading provider of medical devices and contrast products used by radiologists, gastroenterologists and speech language pathologists primarily in screening for and diagnosing diseases and disorders of the gastrointestinal (GI) tract. We develop, manufacture and market medical diagnostic products used for computed tomography (CT) and magnetic resonance (MR) imaging, colorectal cancer screening, evaluation of swallowing disorders (dysphagia), and testing for other diseases and disorders of the GI system. Additionally, we sell RSDL TM - a liquid skin decontaminant that neutralizes or removes chemical warfare agents such as Sarin or VX in seconds, leaving a non-toxic liquid that can be washed away with water to the U.S. and Canadian armed forces and branches of a number of other armed forces in Europe and elsewhere. We also leverage our capacities in manufacturing, automation and quality control by providing contract manufacturing services to third-parties.
President & CEO
Anthony A. LombardoNumber of Employees 590
Peer Companies
NAICS Code Surgical and Medical Instrument Manufacturing: 339112
News & Analysis
Filter by
e-z-em inc. - All News and Analysis
E-Z-EM Inc. Expands Manufacturing Capacity for Its RSDL™ Skin Decontaminants
LAKE SUCCESS, N.Y. -- E-Z-EM Inc. (Nasdaq:EZEM) announced today that it has completed a multi-million dollar expansion of its Canadian manufacturing facility used for the production of RSDLTM decontamination lotion. Located at E-Z-EM's current Good Manufacturing Practices cGMP pharmaceutical facility in Montreal, Canada, the expansion provides a significant increase in...
E-Z-EM Launches www.RSDecon.com Site for RSDL
LAKE SUCCESS, N.Y. -- E-Z-EM, Inc. (NASDAQ:EZEM) today announced the launch of www.RSDecon.com, a new website dedicated to the Company's Reactive Skin Decontamination Lotion (RSDLTM) product. The Company developed the site to provide an informative resource for the military and emergency first responder personnel who make up the two primary...
Parent Firm to Spin Off Queensbury, N.Y., Medical Device Maker AngioDynamics.
By Kevin Harlin, Times Union, Albany, N.Y. Knight Ridder/Tribune Business News Mar. 9--The parent of AngioDynamics Inc. will spin off the Queensbury medical device maker with an initial public offering of stock that is expected to raise $30.6 million. ...
U.S. Army testing E-Z-EM chemical warfare lotion
E-Z-EM Inc. (AMEX: EZM) said Monday the U.S. Army has signed a contract for the final testing of a skin decontamination lotion that it manufactures. E-Z-EM produces the Reactive Skin Decontamination Lotion for Cambridge, Ontario-based O'Dell Engineering Ltd. The Army will buy limited quantities of the...
Four new tenants sign lease at i.park site
The New York Mercantile Exchange leads the list of four new tenants taking space at i.park, which is attracting significant interest despite current economic woes. The NYMEX has signed to lease 40,000 square feet of space at the former Sperry and Lockheed Martin facility that once served...
E-Z-EM, Inc. Corrects Factors' Impact on Earnings; $418,000, or $.04 per basic share Sted $337,000, or $.03 per basic share
Health/Medical Editors CORRECTION...by E-Z-EM, Inc. --BUSINESS WIRE In BW2556, (NY-E-Z-EM) reports financial results, third graph, second line should read $418,000, or $.04 per basic share (sted $337,000, or $.03 per basic share).
E-Z-EM, Inc., Announces Preliminary Results for First Quarter Fiscal 2000
WESTBURY, N.Y.--BUSINESS WIRE--Sept. 30, 1999--
E-Z-EM Inc. Proceeding With Plans To Market New MRI Contrast Agent
WESTBURY, N.Y.--HealthWire--Jan. 7, 1997-- Approvable Letter From FDA On New Drug Application Received By Manufacturer of GADOLITER Oral Suspension E-Z-EM Inc. (AMEX: EZM.A and EZM.B) today announced that Pharmacyclics Inc., the manufacturer of GADOLITER Oral Suspension, has received a letter from the Food and...
E-Z-EM Inc. introduces contrast agent for new "see-through" small bowel radiographic study; Entero Vu™ provides detailed images not possible with conventional small bowel x-ray examination
WESTBURY, N.Y.--HealthWire--Sept. 5, 1996--A new procedure for imaging the small bowel was introduced today by E-Z-EM Inc. (AMEX:EZMA and EZMB).Referred to as a "see-through" small bowel radiographic study, the procedure employs E-Z-EM's newly developed contrast agent marketed under the name Entero VuTM.Archie Williams, E-Z-EM's Vice President of Imaging Products describes...
E-Z-EM, Inc
E-Z-EM, Inc., Westbury, N.Y., says its AngioDynamics division kicked off its initial offshore sales of [CO.sub.2]ject[TM], a new system for angiographic procedures that uses carbon dioxide contrast agents instead of the more costly iodinated media used in most of today's procedures. [CO.sub.2]ject has been cleared for sale in Australia, Spain...
- 1
- 2
Decision Makers
| Name (plus bio) | Position |
|---|---|
| Anthony A. Lombardo | President & CEO |
| Dennis Curtin | E-Z-Em Chief Financial Officer |
| Joseph A. Cacchioli | Controller, Acting Cfo & Vice President |
| Peter J. Graham | Chief Legal Officer, Secretary & Senior Vice President, Global Hr |
| Brad Schreck | The Company's Senior Vice President, Global Sales, Marketing and Engineering |
| Jeffrey Peacock | Senior Vice President |
| Archie B. Williams | Vice President, Clinical Affairs & Medical Community Liaison |
| Robert M. Bloomfield | Vice President, Market Res |
| Sandra Baron | Vice President, Global HR |
| Timothy G Henry | Vice President and General Manager of E-Z-Em's Healthcare Decontamination Business |
| Robert J. Beckman | Founder and Managing Partner of The Channel Group |
| Michael A. Davis | Medical Director |
| Steve Carden | Director, Marketing |
| Tom Johnson | Director, Marketing |
| John T Preston | Principal Accountant Fees and Services |
| Linda B Stern | |
| S Stern Howard | |
| Paul S. Echenberg | Director |
Board of Directors
| Name (plus bio) | Position |
|---|---|
| Adel Michael | Board of Directors |
| David P. Meyers | Board of Directors |
| Donald A. Meyer | Board of Directors |
| George P. Ward | Board of Directors |
| Howard S. Stern | Board of Directors |
| James H. Thrall | Board of Directors |
| Organization | Position | Status |
|---|---|---|
| E-Z-EM, Inc. | President & CEO | Current |
| E-Z-EM, Inc. | Board of Directors | Current |
| E-Z-EM Imaging Products Division | President | Former |
| Organization | Position | Status |
|---|---|---|
| E-Z-EM, Inc. | E-Z-Em Chief Financial Officer | Current |
| Organization | Position | Status |
|---|---|---|
| E-Z-EM, Inc. | Controller, Acting Cfo & Vice President | Current |
| Organization | Position | Status |
|---|---|---|
| E-Z-EM, Inc. | Chief Legal Officer, Secretary & Senior Vice President, Global Hr | Current |
| Angiodynamics, Inc. | Board of Directors | Former |
| Organization | Position | Status |
|---|---|---|
| E-Z-EM, Inc. | The Company's Senior Vice President, Global Sales, Marketing and Engineering | Current |
| Vyteris, Inc. | Consultant | Former |
| Organization | Position | Status |
|---|---|---|
| E-Z-EM, Inc. | Senior Vice President | Current |
| Organization | Position | Status |
|---|---|---|
| E-Z-EM, Inc. | Vice President, Clinical Affairs & Medical Community Liaison | Current |
| Organization | Position | Status |
|---|---|---|
| E-Z-EM, Inc. | Vice President, Market Res | Current |
| Organization | Position | Status |
|---|---|---|
| E-Z-EM, Inc. | Vice President, Global HR | Current |
| Organization | Position | Status |
|---|---|---|
| E-Z-EM, Inc. | Vice President and General Manager of E-Z-Em's Healthcare Decontamination Business | Current |
Robert J. Beckman has been a director of our company since 2002. He is a founder and since 2002 has been a Managing Partner of The Channel Group, a venture management and corporate advisory business focusing on global life sciences. Previously, he founded Intergen Co., a company that provides technology and biologicals to the pharmaceutical/biotechnology and clinical diagnostic industries, and served as its Chief Executive Officer from 1987 until 2001.
| Organization | Position | Status |
|---|---|---|
| E-Z-EM, Inc. | Founder and Managing Partner of The Channel Group | Current |
| Channel Group Inc | Managing Partner | Current |
| E-Z-EM, Inc. | Board of Directors | Current |
| InterGen | Founder | Former |
| Organization | Position | Status |
|---|---|---|
| E-Z-EM, Inc. | Medical Director | Current |
| MacroChem Corporation | Director | Current |
| Morgan Grenfell | Vice President, Corporate Finance | Former |
| University of Massachusetts Medical School | Director of the Division | Former |
| Harvard Medical School | Visiting Professor of Radiology | Former |
| University of Massachusetts Medical School | Professor of Radiology and Nuclear Medicine | Former |
| Radiology | Visiting Professor | Former |
| State University of New York at Stony Brook | Research Prof | Former |
| E-Z-EM, Inc. | Director | Former |
| University of Massachusetts Medical School | M.D. | Former |
| Wharton Graduate School of the University of Pennsylvania | M.B.A. Degree | Former |
| Northeastern University | M.B.A. | Former |
| Worcester Polytechnic Institute | M.S. | Former |
| Worcester Polytechnic Institute | B.S. | Former |
| Boston University | B.S. In Biomedical Engineering | Former |
| University of Massachusetts Medical School | B.S. | Former |
| Northeastern University | S.M. | Former |
| Organization | Position | Status |
|---|---|---|
| E-Z-EM, Inc. | Director, Marketing | Current |
| Organization | Position | Status |
|---|---|---|
| E-Z-EM, Inc. | Director, Marketing | Current |
| Organization | Position | Status |
|---|---|---|
| Massachusetts Institute | President | Current |
| C Change Investments, LLC | Founder | Current |
| C Change Investments, LLC | Managing Partner | Current |
| E-Z-EM, Inc. | Principal Accountant Fees and Services | Current |
| Alseres Pharmaceuticals, Inc. | Chairman | Current |
| Clean Harbors, Inc. | Board of Directors | Current |
| E-Z-EM, Inc. | Board of Directors | Current |
| Biomerix Corporation | Board of Directors | Current |
| The National Institute for Hometown Security | Board of Directors | Current |
| Massachusetts Institute | Senior Lecturer | Current |
| Alseres Pharmaceuticals, Inc. | Director | Current |
| Atomic Ordered Materials | President | Former |
| Northwestern University | MBA | Former |
| University of Wisconsin | BS In Physics | Former |
| Organization | Position | Status |
|---|---|---|
| E-Z-EM, Inc. | Current |
| Organization | Position | Status |
|---|---|---|
| E-Z-EM, Inc. | Current |
| Organization | Position | Status |
|---|---|---|
| E-Z-EM, Inc. | Board of Directors | Current |
| Getz Bros. & Co., Inc. | Chief Financial Officer | Former |
| Getz Bros. & Co., Inc. | Senior Vice President | Former |
| The Marmon Group, Inc. | Group Controller | Former |
| Amphenol Corporation | Controller | Former |
| Mentor Corporation | Vice Chairman of the Board | Former |
David P. Meyers , age 43, has been a director of our company since 1996. He is a founder of Alpha Cord, Inc., which provides cryopreservation of umbilical cord blood, and has served as its President since 2002. Previously, he founded MedTest Express, Inc., an Atlanta, Georgia-based provider of contracted laboratory services for home health agencies, and served as its President, Chief Executive Officer and a director from 1994 to 2002.
| Organization | Position | Status |
|---|---|---|
| Alpha Cord | Founder | Current |
| E-Z-EM, Inc. | Board of Directors | Current |
| Angiodynamics, Inc. | Board of Directors | Former |
| Organization | Position | Status |
|---|---|---|
| E-Z-EM, Inc. | Board of Directors | Current |
| Organization | Position | Status |
|---|---|---|
| E-Z-EM, Inc. | Board of Directors | Current |
| A.L.I. Technologies, Inc | Consultant | Former |
| The Blue Cross | Director | Former |
| A.L.I. Technologies, Inc | Director | Former |
| Organization | Position | Status |
|---|---|---|
| E-Z-EM, Inc. | Board of Directors | Current |
James H. Thrall, M.D. , age 64, has been a director of our company since 2005. He is a radiologist and chairs the Department of Diagnostic Radiology of Massachusetts General Hospital. He is currently a member of the Board of Trustees of the Massachusetts General Physicians Organization. He is also a director of WorldCare, Inc., a company providing telemedicine and clinical trial support services, and has served as Chairman of its board of directors since 1999. Since 2002, he has also been a director of Mobil Aspects Inc., a company focused on radiofrequency identification (RFID) technology, and has served as Chairman of its board of directors since 2005. Dr. Thrall also serves on the Board of Trustees of the Society of Chairman of Academic Radiology Departments, the Board of Chancellors of the American College of Radiology and the Board of Trustees of the Research and Education Foundation of the Radiological Society of North America.
| Organization | Position | Status |
|---|---|---|
| Education Foundation | Board of Directors | Current |
| E-Z-EM, Inc. | Board of Directors | Current |
| World Care | Director | Current |
| Organization | Position | Status |
|---|---|---|
| Apheresis News | Director | Current |
| Sotradecol | Director | Current |
| Cny Medtech | Director | Current |
| MacroChem Corporation | Director | Current |
| Lallemand, Inc. | Director | Current |
| Benvest Capital Inc. | Director | Current |
| Venacure | Director | Current |
| E-Z-EM, Inc. | Director | Current |
| Angiodynamics, Inc. | Director | Current |
| Venacure Evlt(Tm) | Director | Current |
| Sotradecol | Committee Member | Current |
| Angiodynamics, Inc. | Committee Member | Current |
| Harvard Business School | M.B.A. | Former |
| McGill University | B.Sc. | Former |
Industry Transcripts by Seeking Alpha
-
Medtronic Inc. F2Q10 (Qtr End 10/30/09) Earnings Call Transcript
on Nov 24, 2009about MDT
-
ZOLL Medical Corporation F4Q09 (Qtr End 27/09/09) Earnings Call Transcript
on Nov 11, 2009about ZOLL
-
RadNet, Inc. Q3 2009 Earnings Call Transcript
on Nov 09, 2009about RDNT
-
Cytori Therapeutics Q3 2009 Earnings Call Transcript
on Nov 09, 2009about CYTX
-
StoneMor Partners L.P. 3Q09 (Qtr End 9/30/09) Earnings Call Transcript
on Nov 09, 2009about STON
IndustryTop Rated
- Why So Many Insured People Have Big Medical Debts 5 votes
- Physicians Know We Need Reform 4 votes
- Healthcare Roundup: Medical Office Space in Demand, Blues Companies See Lower Income, Two Sides of Health Insurance, and More 3 votes
- Hospital Chain's Turnaround Raises Health Spending 3 votes
- Healthcare Is Still Adding Jobs, Despite Recession 3 votes




